Therefore, the application value of combining real-time USE with serum HE4, IL-33, and CA153 in diagnosing early cervical cancer was explored herein, in the hope of providing reference for establishing clinical treatment scheme and patient condition evaluation. The gene discussed is IL33; the disease is cervical carcinoma.